Bone mineral density in children with familial Mediterranean fever

Duzova, Ali; Ozaltin, Fatih; Ozon, Alev; Besbas, Nesrin; Topaloglu, Rezan; Ozen, S.; Bakkaloglu, A.
June 2004
Clinical Rheumatology;Jun2004, Vol. 23 Issue 3, p230
Academic Journal
The aim of this study was to evaluate bone mineral content (BMC), serum and urinary bone turnover parameters in patients with familial Mediterranean fever (FMF), an autosomal recessive disease characterized by recurrent episodes of inflammation of serous membranes. Demographic characteristics and MEFV mutations were defined in 48 children diagnosed with FMF (23 F, 25 M; median age 7.0 years (3.0–10.0)). We evaluated the blood counts, acute-phase proteins and serum and urinary bone turnover parameters during attack-free periods. The BMC and BA (bone area) of vertebrae L1–L4 were measured by DEXA. Thirty-eight age-, sex- and ethnicity-matched healthy children constituted the control group. Mean L1–L4 BMC in Group I (patients with two mutations) and II (patients with no or single mutations) were 15.49±5.99 g and 15.68±4.89 g, respectively, both significantly lower than the mean L1–L4 BMC of control patients, which was 19.59±6.7 g (p<0.05). Mean L1–L4 BMD in Group I, Group II and the control group were 0.466±0.066 g/cm2, 0.487±0.085 g/cm2 and 0.513±0.079 g/cm2, respectively. Mean z-scores in Group I, Group II and the control group were –1.87±0.74, -1.55±0.92 and –1.39±0.84, respectively. Mean L1–L4 BMD and z-score of Group I were lower than in the control group (p<0.05). ESR and SAA (serum amyloid A) levels were higher in Group I patients: 28.3±14.5 mm/h and 350±62 mg/l in Group I; and 20.5±11.7 mm/h and 190±68 mg/l in Group II, respectively. In conclusion, FMF patients had lower BMC, BMD and z-scores than a control group. We suggest that decreased BMD, BMC and z-score in FMF patients may be secondary to subclinical inflammation.


Related Articles

  • familial Mediterranean fever. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p298 

    An encyclopedia entry for "familial Mediterranean fever" is presented. It refers to an inherited condition of an unknown cause. It generally affects certain Sephardic Jewish, Armenian, and Arab families. Some of the symptoms of familial Mediterranean fever include recurrent fever, abdominal and...

  • Amyloid Deposition in a Renal Transplant in Familial Mediterranean Fever. Benson, Merrill D.; Skinner, Martha; Cohen, Alan S. // Annals of Internal Medicine;Jul77, Vol. 87 Issue 1, p31 

    A patient with familial Mediterranean fever and amyloldosis who received a cadaver renal transplant 6½ years ago was studied to determine the relation of the serum precursor of secondary amylold (SAA) to the clinical course and to the deposition of amyloid In the transplant. Amyloid fibrils...

  • familial Mediterranean fever.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p846 

    An encyclopedia entry for "familial Mediterranean fever" is presented.

  • Efficacy of colchicine therapy in amyloid nephropathy of familial Mediterranean fever. Öner, Ayşe; Erdoğan, Özlem; Demircin, Gülay; Bülbül, Mehmet; Memiş, Leyla // Pediatric Nephrology;Jun2003, Vol. 18 Issue 6, p521 

    The aim of this study was to investigate the effect of colchicine therapy on the outcome of amyloid nephropathy of familial Mediterranean fever (FMF) in childhood. The diagnosis of amyloidosis type AA was confirmed by renal biopsy in 38 patients. During a mean follow-up period of 30.5 months...

  • FAMILIAL MEDITERRANEAN FEVER. Eisenstadt, H. B. // American Journal of Gastroenterology;Nov1959, Vol. 32 Issue 5, p651 

    Presents an abstract of the study "Familial Mediterranean Fever," by Harry Heller, Ezra Sohar and Libby Sherf, published in the July 1958 issue of the "Archives of Internal Medicine."

  • Familial Mediterranean Fever. Mellinkoff, Sherman M; Snodgrass, Richard W.; Schwabe, Arthur D.; Mead, James F.; Weimer, Henry E.; Frankland, Marjorie // Annals of Internal Medicine;Feb62, Vol. 56 Issue 2, p171 

    Discusses clinical and laboratory features of familial Mediterranean fever. Serum protein levels; Impact of diet; Laboratory findings relevant to understanding the pathogenesis of the disease.

  • Higher than expected carrier rates for familial Mediterranean fever in various Jewish ethnic groups. Stoffman, N; Magal, N; Shohat, T; Lotan, R; Koman, S; Oron, A; Danon, Y; Halpern, G J; Lifshitz, Y; Shohat, M // European Journal of Human Genetics;Apr2000, Vol. 8 Issue 4, p307 

    Familial Mediterranean fever (FMF) is an autosomal recessive disease characterised by recurrent attacks of inflammation of serosal membranes. Amyloidosis leading to renal failure is the most severe complication in untreated patients. In Israel FMF is most frequent among Jews of North African...

  • Familial Mediterranean fever. Onen, Fatos // Rheumatology International;Apr2006, Vol. 26 Issue 6, p489 

    Familial Mediterranean fever (FMF) is the most frequent hereditary inflammatory disease characterized by self-limited recurrent attacks of fever and serositis. It is transmitted in an autosomal recessive pattern and affects certain ethnic groups mainly Jews, Turks, Arabs, and Armenians. FMF is...

  • Serum Leptin Is not a Diagnostic Marker for Familial Mediterranean Fever Attacks. Toy, B�lent; Tar�in, Orhan; Bagci, Sait; �st�ndag, Y�cel; Inal, Ali; Tiftik�i, Arzu // Mediators of Inflammation;4/1/2006, Vol. 2006 Issue 2, p1 

    The aim of our study is to determine whether there is a relationship between familial Mediterranean fever (FMF) attacks and serum leptin levels. We enrolled 25 patients (22 males and 3 females) and 25 healthy controls (21 males and 4 females) with a mean age of 24.42 � 1.22 (Mean �...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics